Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
N4 Pharma ( (GB:N4P) ) just unveiled an update.
N4 Pharma has appointed Edward Wardle as a Non-Executive Director, representing the company’s largest shareholder, Northern Standard Limited. His expertise in strategy, corporate governance, and business development is expected to bolster N4 Pharma’s efforts in advancing its Nuvec® platform and securing licensing opportunities, potentially transforming drug delivery methods in the industry.
More about N4 Pharma
N4 Pharma is a UK-based biotechnology company focused on developing Nuvec®, a proprietary gene delivery system designed to enable advanced therapies for cancer and other diseases.
Average Trading Volume: 1,631,708
Technical Sentiment Signal: Sell
Current Market Cap: £5.71M
For detailed information about N4P stock, go to TipRanks’ Stock Analysis page.